You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DESTINY-Breast08

Showing 1 - 25 of 6,226
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +6 more
  • Iowa City, Iowa
  • +60 more
Jan 3, 2023

DESTINY Breast Respond HER2-low Europe

Not yet recruiting
  • Unresectable Breast Cancer
  • +2 more
  • Trastuzumab deruxtecan
  • (no location specified)
Jul 6, 2023

Breast Cancer Trial (Trastuzumab Deruxtecan)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • (no location specified)
Jul 10, 2023

Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)

Recruiting
  • Breast Cancer
  • Chicago, Illinois
    University of Illinois
Oct 18, 2023

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +4 more
  • West Hollywood, California
  • +101 more
Jan 16, 2023

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Brussels, Barcelona, Madrid (JK08)

Recruiting
  • Cancer
  • +6 more
  • Brussels, Belgium
  • +3 more
Jan 30, 2023

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

Active, not recruiting
Has Results
  • Breast Cancer
  • Trastuzumab deruxtecan (T-DXd)
  • Ado-trastuzumab emtansine (T-DM1)
  • Los Angeles, California
  • +163 more
Apr 1, 2022

Breast Cancer and Ovarian Cancer Trial (SPARC-08-038, Ref-08-038)

Completed
  • Breast Cancer and Ovarian Cancer
  • (no location specified)
Jul 22, 2021

Breast Cancer Trial in Worldwide (DS-8201a)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alaska
  • +98 more
Oct 17, 2022

Breast Cancer, Cancer Trial in Worldwide (Nivolumab, Anastrozole, Palbociclib)

Completed
Has Results
  • Breast Cancer
  • Cancer
  • Nivolumab
  • +2 more
  • Whittier, California
  • +35 more
Jul 14, 2022

Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan)

Recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • San Diego, California
  • +90 more
Jul 19, 2022

Acute Coronary Syndrome, Ischemic Heart Disease Trial in Shanghai, Seoul (CCTA-derived high risk plaque characteristics,

Active, not recruiting
  • Acute Coronary Syndrome
  • Ischemic Heart Disease
  • CCTA-derived high risk plaque characteristics
  • CFD-derived hemodynamic parameters
  • Shanghai, China
  • +1 more
Sep 6, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +3 more
  • Chandler, Arizona
  • +226 more
Aug 11, 2022

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer Trial in Worldwide (Administration of

Recruiting
  • Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
  • Administration of ceralasertib in combination with carboplatin
  • +3 more
  • Duarte, California
  • +26 more
Aug 17, 2022

HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer Trial in Worldwide (DS-8201a, T-DM1)

Recruiting
  • HER2-Positive Primary Breast Cancer
  • Residual Invasive Breast Cancer
  • Anaheim, California
  • +505 more
Feb 2, 2023

Breast Cancer; HER2-positive; Metastatic Trial in Worldwide (Trastuzumab deruxtecan, Placebo, Taxane)

Recruiting
  • Breast Cancer; HER2-positive; Metastatic
  • Trastuzumab deruxtecan
  • +4 more
  • Phoenix, Arizona
  • +329 more
Jan 10, 2022

Colorectal Tumors Trial in China (Disitamab vedotin, Tislelizumab)

Recruiting
  • Colorectal Neoplasms
  • Changzhou, Jiangsu, China
  • +5 more
Aug 7, 2022

Locally Advanced or Metastatic NSCLC Trial in Worldwide (Trastuzumab Deruxtecan, Cisplatin, Carboplatin)

Recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Trastuzumab Deruxtecan
  • +4 more
  • Anchorage, Alaska
  • +148 more
Aug 11, 2022

Advanced Cancer Trial in Worldwide (Nivolumab, Daratumumab)

Completed
Has Results
  • Advanced Cancer
  • Nivolumab
  • Daratumumab
  • Long Beach, California
  • +19 more
Jul 2, 2021

Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric,

Active, not recruiting
  • Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
  • Trastuzumab deruxtecan
  • Santa Rosa, California
  • +29 more
Jun 14, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan (DS-8201a)
  • +5 more
  • Chandler, Arizona
  • +207 more
Jan 25, 2022

Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Trastuzumab Deruxtecan
  • +5 more
  • Springdale, Arkansas
  • +203 more
Jan 13, 2023

Triple-Negative Breast Cancer Trial in Worldwide (Atezolizumab, Nab-Paclitaxel)

Active, not recruiting
  • Triple-Negative Breast Cancer
  • Buenos Aires, Argentina
  • +75 more
Nov 21, 2022

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole or Anastrozole, Goserelin)

Active, not recruiting
  • Breast Cancer
  • Mobile, Alabama
  • +90 more
Dec 19, 2022

Adenocarcinoma Gastric Stage IV With Metastases, Adenocarcinoma - GEJ Trial in Worldwide (Trastuzumab deruxtecan)

Active, not recruiting
Has Results
  • Adenocarcinoma Gastric Stage IV With Metastases
  • Adenocarcinoma - GEJ
  • Trastuzumab deruxtecan
  • Duarte, California
  • +36 more
Jan 24, 2022